Proscia and UCSF Partner to Deliver Artificial Intelligence Applications That Improve the Accuracy and Speed of Cancer Diagnosis

11:59 EST 3 Mar 2020 | Speciality Pharma Journal

PHILADELPHIA & SAN FRANCISCO–(BUSINESS WIRE)–Proscia, a leading provider of artificial intelligence (AI) enabled digital pathology solutions, and the University of California, San Francisco (UCSF) have partnered to introduce artificial intelligence into the practice of pathology. Beginning with prostate cancer, the second leading cause of cancer deaths among men in the U.S., the collaboration will validate …

More From BioPortfolio on "Proscia and UCSF Partner to Deliver Artificial Intelligence Applications That Improve the Accuracy and Speed of Cancer Diagnosis"